|
HS Code |
577939 |
| Chemical Name | (S)-2-Methylpyrrolidine Hydrochloride |
| Cas Number | 247038-10-4 |
| Molecular Formula | C5H12ClN |
| Molecular Weight | 121.61 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 137-139°C |
| Optical Activity | [α]D20 −70° (c=1, H2O) |
| Solubility | Soluble in water |
| Purity | Typically ≥98% |
| Smiles | C[C@@H]1CCCN1.Cl |
| Inchi | InChI=1S/C5H11N.ClH/c1-5-3-2-4-6-5;/h5-6H,2-4H2,1H3;1H/t5-/m0/s1 |
As an accredited (S)-2-Methylpyrrolidine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | (S)-2-Methylpyrrolidine Hydrochloride, 25g, is packaged in a sealed amber glass bottle with a tamper-evident cap and hazard labeling. |
| Shipping | (S)-2-Methylpyrrolidine Hydrochloride is shipped in secure, airtight containers to prevent moisture absorption and contamination. Packaging complies with chemical safety regulations. The product is labeled with hazard information and requires handling by trained personnel. Shipping is typically done via ground or air, depending on destination and urgency, with appropriate documentation and tracking provided. |
| Storage | (S)-2-Methylpyrrolidine Hydrochloride should be stored in a tightly sealed container at room temperature, away from moisture, heat, and direct sunlight. Keep it in a well-ventilated, dry area, separated from incompatible substances such as strong oxidizers and bases. Ensure proper labeling and restrict access to trained personnel to maintain chemical stability and safety. |
Applications of (S)-2-Methylpyrrolidine Hydrochloride in Industrial ManufacturingAs a dedicated producer of (S)-2-Methylpyrrolidine Hydrochloride, we provide this chiral intermediate to global customers for use in pharmaceutical synthesis, agrochemical R&D, specialty chemical production, and advanced material workflows. The following industrial application scenarios reflect established downstream uses, including precise technical, regulatory, and process requirements for each sector. 1. Chiral Pharmaceutical Intermediate SynthesisThis material acts as a stereospecific building block in active pharmaceutical ingredient (API) manufacturing, especially for the synthesis of small-molecule therapeutics requiring defined absolute configuration. Formulation chemists introduce it during multi-step synthesis of alkaloid analogs and CNS drug candidates. Chirality control is managed under validated cGMP reactors, with batch records documenting precise input dosages based on target substrate requirements. QC teams monitor for enantiopurity and residual solvent content per regulatory specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Chiral Auxiliary ManufacturingAgrochemical formulators source this raw material for efficient synthesis of chiral auxiliaries and crop protection agent intermediates. Field-proven applications include the construction of pyrrolidine-containing herbicide and insecticide scaffolds, where stereochemistry influences biological selectivity and regulatory assessment. Industrial teams weigh input ratios based on required chiral enrichment and analytical batch performance, with all steps cross-checked under ISO quality frameworks and documented traceability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fine Chemical Enantioselective SynthesisProducers of advanced fine chemicals utilize (S)-2-Methylpyrrolidine Hydrochloride in the preparation of chiral ligands and specialty synthons for organocatalysis and stereoselective reactions. Its role as a resolving agent or precursor ensures high enantiomeric excess in output batches, with process engineers using automated feeders for precise volumetric incorporation. Downstream recovery procedures include purification by crystallization or chromatography, monitored using calibrated chiral-HPLC systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research and Development of Chiral Reference StandardsInstitutes and quality control laboratories depend on our material for the reliable synthesis of chiral reference standards. These standards enable method validation in enantiomeric purity testing and regulatory submissions. Bench chemists measure and dissolve specified aliquots for calibration curve preparation, following documented protocols to maintain reproducibility. All R&D batches undergo full spectral and chromatographic certification, with full chain-of-custody records for regulatory audit trails. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (S)-2-Methylpyrrolidine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every batch of (S)-2-Methylpyrrolidine Hydrochloride tells a story of careful selection, rigorous process control, and practical problem solving. Over years spent refining each aspect of its manufacture, we have witnessed how subtle details make a tangible difference for chemists and researchers making use of this chiral building block. The compound, known by its CAS as 1445-76-3, meets the needs of those seeking a reliable source for asymmetric synthesis and pharmaceutical research. Seeing firsthand the challenges users face—batch inconsistencies, low enantiomeric purity, and variable crystalline forms—drove our efforts to tighten process parameters and offer clear, dependable assurances on every shipment.
Most requests focus on crystalline (S)-2-Methylpyrrolidine Hydrochloride in its hydrochloride salt form. Through years of scaling, we have landed on a process that consistently delivers high purity, white to off-white crystals, with the kind of moisture content and melting point profiles seasoned researchers expect. Purity by HPLC stands above 99% enantiomeric excess (ee), with GC and NMR confirming the chemical integrity. From pilot scale laboratories to larger process plants, users rarely need to filter or further purify. Control over micron-size distribution and final drying is not just for specification—it directly assists in downstream handling and rapid dissolution, letting our customers spend time on synthesis rather than on reprocessing or troubleshooting material that doesn’t behave predictably.
Unlike the racemic base often used in less selective syntheses, our (S)-isomeric form opens doors for chiral resolution and process simplification. The hydrochloride salt enables better handling, improved shelf life, and easier weighing compared to the corresponding free base, which tends to be volatile and hygroscopic, complicating storage and transfer. Over the years, feedback from frequent users has pushed us to evaluate incoming raw materials and workflow steps with an eye on repeatability, pushing yields and optical purity higher while reducing waste.
Chemists seeking to build up structure with a chiral center count on the reliability of each input. In peptide research, agrochemical routes, and early candidate screening for small-molecule drugs, even tiny shifts in stereochemistry lead to very different results in biological testing. With our (S)-2-Methylpyrrolidine Hydrochloride, the outcome reflects years of refining hydrogenation steps, solvent selections, and quenching protocols—not just theory, but lessons learned from every batch that yielded less than targeted yield or optically impure material.
Down in the plant, color, particulate inspection, and real-world dissolution tests pull more weight than certificates. We’ve learned most end users value the assurance that comes from lot-to-lot repeatability—being able to scale up or switch suppliers without introducing new headaches halfway through an important project. This also means our technical staff can speak from knowledge about solvent compatibilities, reactivity in specific synthesis steps, and clean-up procedures for those looking to minimize side products and maximize downstream yield.
Major differences arise in basic handling and problem avoidance. The free base form—while lighter to ship—often arrives as oil, especially if storage falls below freezing. This can set users back days, as the free base sometimes requires redistillation or basification just to get started. Hydrochloride salt, by contrast, packs easily, scoops cleanly, and stays crisp in ambient conditions. Having trialed various packaging materials, we settled on multilayer-lined containers after users described static charge issues in certain plastics, especially in dry climates.
Compared to alternative suppliers, feedback from contract manufacturers and academic groups points to our control over optical purity as the deciding factor. Many have shared that reducing enantiomeric purity by as little as half a percent can devastate preparative schemes, lead to lower yield of target enantiomer in final API, or produce results that simply cannot be explained to regulatory reviewers. Tight specifications—confirmed for every drum, not just spot-checked—arise from our investment in process chemistry and analytical improvements, not marketing.
The true test of a chemical’s value comes in the hands of those using it to solve problems. Working alongside process chemists and route-scouting teams, we have contributed to the development of several pharmaceutical intermediates, asymmetric catalysts, and chiral auxiliaries. From gram to ton scale, batch records support regulatory submission and batch-release documentation. We recognize delays or inconsistencies in early R&D ripple throughout years of downstream development.
One specific example involved a project where enantioselectivity in a hydrogenation step dictated the overall synthesis path for a CNS drug candidate. The client’s own efforts using generic material produced a persistent impurity that clouded both analytical results and downstream step performance. After switching to our material, not just high purity but tighter water content and sharper melting point curves meant each batch demonstrated better reproducibility, purer downstream intermediates, and less time lost in purification. That kind of tangible improvement drives every upgrade we make.
The learning curve in making (S)-2-Methylpyrrolidine Hydrochloride never truly flattens. Every couple of years, raw material sources fluctuate, new impurities sneak in through feedstock, or regulatory controls on solvents shift. We take nothing as permanent except the push for higher purity, finer control of isomer ratios, and better yield. Chemists are all too familiar with glossy marketing descriptions—what matters is material that performs consistently from the first gram to the hundredth kilo.
Many process insights come from listening—not just reviewing complaints, but following up on results in downstream syntheses, screening for minor residual solvents that might trip up an HPLC, and even tracing back batches with unexpected discoloration due to subtle oxidation or over-exposure. Alongside in-house quality teams, we regularly collaborate with experienced third-party labs, relying on mass spectrometry, chiral HPLC, and Karl Fischer titration to check both what should and should not be present in every shipment. These extra steps are rarely in the spec, but they save partners real money and time.
Not every process change boosts yield or reduces cost in a straight line. At several points, we faced trade-offs between minimizing residual salt content and keeping process steps manageable. Given market pressure, skimping on quenching or washing looked tempting but led to sticky, hard-to-handle crystals. That set off more downstream headaches, with customers reporting reduced solubility or unexpected results in chromatography. As manufacturers, we know the workload generated by shortcuts—whether it ends up affecting ourselves or the chemists using our product. Tight control over drying cycles, solvent switches, and inert-gas handling grew from these lessons, even if it meant longer cycle times or pricier raw materials.
Real improvement often follows feedback loops—years ago, recurring complaints about clumping in high-humidity shipping months led us to test packaging under a range of conditions well beyond what our specification required. One winter, drums sent by air to a customer in Scandinavia arrived compacted into single hard lumps. Since then, we package with controlled-atmosphere liners and regularly inspect our shipping partners for best practices. Learning directly from those close to the bench builds these safeguards into every delivery.
Chiral intermediates source from a wide range of producers, many of whom operate tolling lines or offer bulk chemicals as a sideline to their larger commodity portfolios. Our focus remains narrow—drawing from a process line designed, monitored, and adjusted solely for target optical purity and user predictability. Over time, we’ve seen market entrants bulk up on lower-cost, racemic mixtures, offering an ad hoc separation step as an add-on. That approach often leaves residual base or half-converted salt, leading to the stubborn impurity that keeps reappearing, batch after batch, in downstream chemistry.
Reports from researchers often cite issues with variable polymorph content—a sometimes-overlooked problem that means a bottle from one run dissolves readily while another clumps or leaves visible residue. By focusing on tight process windows and rigorous solid-state analysis, we commit to providing crystalline hydrochloride with no mix of forms from different crystallization cycles. Cost pressures in our market always lurk, but over time, relationships hold when materials perform consistently, not simply when prices momentarily dip.
Quality control isn’t just paperwork. Every hour invested in tighter screening, earlier impurity detection, and transparent documentation means less troubleshooting and process deviation for partners. Our QC team runs side-by-side with both production and R&D, sampling at every critical process step, not just at final packaging. We trace all deviations to root cause and involve chemists in designing corrective steps, closing the loop between manufacturing realities and application needs.
End-users have shared that switching to a manufacturer’s product, as opposed to a repackaged trade batch, brings greater access to data, deeper process insight, and faster troubleshooting. Direct lines between manufacturing and application scientists open possibilities for fine-tuning specifications or batch sizes on short notice. Over many projects, customers point out difficulties tracing the genealogy of problem material when sourced through layers of distributors. By focusing solely on direct manufacture and delivery, we keep communication open, with clear records and access to every testing dataset relevant to each order.
Markets change—new chiral syntheses, fresh regulatory requirements, broader QC expectations, all affect the path from raw material to delivered product. Over the last decade, input from users working on complex syntheses or more sensitive analytical routes has led us to rethink not just how we make (S)-2-Methylpyrrolidine Hydrochloride, but how we store and deliver it. Investments in closed-transfer containers, temperature-control options for large orders, and digital batch records stemmed from plainly stated pain points in scaling R&D to pilot or commercial runs.
Partnerships with academic researchers and process chemists continue to drive incremental improvements. Often, a straightforward suggestion, such as layering in steps for humidity testing or adding a second round of optically active impurity screens, unlocks a new layer of dependability for everyone in the chain. Remaining open to course corrections and incremental gains gives us confidence in facing ever-tightening quality standards—whether for pharma, agro, or specialty chemical innovation.
Anyone who has handled both good and mediocre chiral intermediates knows every shortcut leaves traces. By building every batch of (S)-2-Methylpyrrolidine Hydrochloride with close attention to upstream and downstream realities, we make a compound that isn’t just another line in the catalog but an enabling tool for essential chemistry. Long hours spent tweaking processes, running extra tests, and answering detailed end-user questions show up not just in specs but in smoother project progress and better end-product outcomes.
Working as a manufacturer teaches humility. Every new challenge—be it raw material purity, shipping constraints, or evolving customer needs—forces deeper engagement, sharper attention, and, occasionally, tough decisions. Our process, shaped by experience, evolves with these challenges. Reliable, consistent, and made with respect for those working in the lab, (S)-2-Methylpyrrolidine Hydrochloride stands as a testament to shared goals: bringing ambitious chemistry into the real world, batch after batch.